ArticleMolecular biology reports2026
Expanding the genetic spectrum of neurogenetic disorders in moroccan families by exome sequencing: identification of candidate variants in RYR3, POLR3A, and LAMA2.
Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe diagnosis of neurogenetic disorders is often prolonged due to clinical variability and significant genetic heterogeneity, making molecular diagnosis challenging. This study aimed to investigate the molecular basis of rare inherited neurological conditions in three consanguineous Moroccan families.
methodsWe performed Whole exome sequencing (WES) on probands from three unrelated consanguineous Moroccan families (NP 69, NP 84, NP 89). Candidate variants were validated by Sanger sequencing and segregated within the families. Pathogenicity was assessed through in silico prediction tools. Molecular modeling and molecular dynamics simulations were applied to assess the structural impact of selected variants.
resultsWhole exome sequencing revealed likely disease-causing variants in all three families. In Family NP 69, we found compound heterozygous missense variants in RYR3 gene (p.Gly2168Arg and p.Val854Ile) in a proband presenting with developmental delay and hippocampal sclerosis. In Family NP 84, a homozygous missense variant (p.Trp671Arg) in POLR3A gene, was associated with classic hypomyelinating leukodystrophy and ataxia, but with atypical features including preserved cognition, myoclonus, and oligodontia, consistent with recurrence of a previously reported variant in North Africa and suggestive of a possible founder effect. In Family NP 89, a homozygous splice-site mutation in LAMA2 gene (c.8244 + 1G > A) was confirmed in a proband with severe congenital muscular dystrophy.
conclusionThis study reports a novel compound heterozygous configuration in RYR3, confirms a previously reported bi-allelic variant in POLR3A, and validates a recurrent LAMA2 variant. Together, these findings add new insights into the genotype-phenotype spectrum of neurogenetic disorders in consanguineous North African populations, all consistent with a shared autosomal recessive inheritance pattern.
Indexed as
Identifiers
42113100What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.